Narrative Update • Aug 20
Have your own idea? Try our Stock Screener
Indian (NIFTY) Healthcare Sector Analysis
UpdatedAug 21, 2026
DataAggregated Company Financials
Companies329
- 7D-0.4%
- 3M8.4%
- 1Y12.8%
- YTD16.8%
Last week, the Healthcare industry hasn't moved much but Ipca Laboratories is up 10% in that time. As for the the longer term, the industry is up 13% over the past 12 months. Earnings are forecast to grow by 21% annually.
Sector Valuation and Performance
Has the Indian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 22 Aug 2026 | ₹37.0t | ₹6.5t | ₹837.1b | 31.1x | 44.2x | 5.7x |
| Mon, 20 Jul 2026 | ₹34.9t | ₹6.1t | ₹806.8b | 32x | 43.3x | 5.7x |
| Wed, 17 Jun 2026 | ₹32.9t | ₹6.1t | ₹806.6b | 31.2x | 40.8x | 5.4x |
| Fri, 15 May 2026 | ₹32.7t | ₹6.0t | ₹779.8b | 31x | 42x | 5.5x |
| Sun, 12 Apr 2026 | ₹29.8t | ₹5.9t | ₹780.6b | 29.3x | 38.1x | 5x |
| Tue, 10 Mar 2026 | ₹30.0t | ₹5.9t | ₹780.6b | 27.5x | 38.5x | 5.1x |
| Thu, 05 Feb 2026 | ₹29.4t | ₹5.8t | ₹769.4b | 29.4x | 38.2x | 5.1x |
| Sat, 03 Jan 2026 | ₹30.5t | ₹5.7t | ₹772.6b | 33.8x | 39.5x | 5.3x |
| Mon, 01 Dec 2025 | ₹30.8t | ₹5.7t | ₹767.7b | 33x | 40.2x | 5.4x |
| Wed, 29 Oct 2025 | ₹30.7t | ₹5.5t | ₹736.7b | 35.7x | 41.7x | 5.6x |
| Fri, 26 Sep 2025 | ₹30.3t | ₹5.5t | ₹730.2b | 36.9x | 41.5x | 5.5x |
| Sun, 24 Aug 2025 | ₹30.7t | ₹5.5t | ₹730.0b | 36.3x | 42.1x | 5.6x |
| Tue, 22 Jul 2025 | ₹31.0t | ₹5.3t | ₹732.0b | 37.7x | 42.3x | 5.8x |
| Thu, 19 Jun 2025 | ₹29.3t | ₹5.3t | ₹728.3b | 36.4x | 40.2x | 5.5x |
| Sat, 17 May 2025 | ₹28.6t | ₹5.3t | ₹705.9b | 34.6x | 40.6x | 5.4x |
| Mon, 14 Apr 2025 | ₹28.1t | ₹5.2t | ₹680.2b | 32.8x | 41.3x | 5.4x |
| Wed, 12 Mar 2025 | ₹26.7t | ₹5.2t | ₹680.1b | 31.2x | 39.3x | 5.1x |
| Fri, 07 Feb 2025 | ₹29.1t | ₹5.2t | ₹665.0b | 35.8x | 43.8x | 5.7x |
| Sun, 05 Jan 2025 | ₹30.2t | ₹5.0t | ₹648.5b | 39.3x | 46.6x | 6x |
| Tue, 03 Dec 2024 | ₹29.1t | ₹5.0t | ₹642.9b | 39.1x | 45.3x | 5.8x |
| Thu, 31 Oct 2024 | ₹28.6t | ₹4.9t | ₹618.5b | 41x | 46.2x | 5.8x |
| Sat, 28 Sep 2024 | ₹29.4t | ₹4.9t | ₹605.3b | 42.9x | 48.6x | 6x |
| Mon, 26 Aug 2024 | ₹27.9t | ₹4.9t | ₹602.6b | 38.5x | 46.4x | 5.7x |
| Wed, 24 Jul 2024 | ₹25.5t | ₹4.7t | ₹555.5b | 36.8x | 45.9x | 5.4x |
| Fri, 21 Jun 2024 | ₹24.0t | ₹4.6t | ₹546.3b | 36x | 43.9x | 5.2x |
| Sun, 19 May 2024 | ₹23.3t | ₹4.7t | ₹542.7b | 35.7x | 42.9x | 5x |
| Tue, 16 Apr 2024 | ₹22.7t | ₹4.6t | ₹512.8b | 33.7x | 44.3x | 4.9x |
| Thu, 14 Mar 2024 | ₹21.9t | ₹4.6t | ₹512.5b | 31.5x | 42.8x | 4.8x |
| Sat, 10 Feb 2024 | ₹22.7t | ₹4.5t | ₹511.2b | 37.9x | 44.4x | 5x |
| Mon, 08 Jan 2024 | ₹21.2t | ₹4.4t | ₹476.9b | 37.1x | 44.5x | 4.8x |
| Wed, 06 Dec 2023 | ₹19.7t | ₹4.4t | ₹476.1b | 33.2x | 41.4x | 4.5x |
| Fri, 03 Nov 2023 | ₹17.8t | ₹4.3t | ₹461.1b | 32x | 38.6x | 4.1x |
| Sun, 01 Oct 2023 | ₹18.3t | ₹4.3t | ₹451.6b | 33x | 40.5x | 4.3x |
| Tue, 29 Aug 2023 | ₹17.8t | ₹4.2t | ₹450.7b | 31.4x | 39.5x | 4.2x |
Price to Earnings Ratio
39.5x
Current Industry PE
- Investors are relatively neutral on the Indian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 42.3x.
- The industry is trading close to its 3-year average PS ratio of 5.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 23% per year over the last three years.
- Revenues for these companies have grown 15% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare sector?
| IN Market | -0.52% | |
| Healthcare | -0.45% | |
| Life Sciences | 0.72% | |
| Healthtech | 0.47% | |
| Healthcare Services | -0.17% | |
| Pharma | -0.66% | |
| Biotech | -1.81% | |
| Medical Equipment | -2.45% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 71.4x.
- Analysts are expecting annual earnings growth of 47.1%, which is higher than its past year's earnings growth of 28.6% per year.
- Investors are most pessimistic about the Pharma industry, which is trading close to its 3-year average of 36.6x.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 47% over the next 5 years.
- This is better than its past earnings growth rate of 29% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 18% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IPCALAB Ipca Laboratories | ₹1.91k | 10.2% +₹44.9b | 34.7% | PE37x | |
| 500660 GlaxoSmithKline Pharmaceuticals | ₹2.90k | 7.8% +₹35.7b | 3.6% | PE46x | |
| DIVISLAB Divi's Laboratories | ₹8.60k | 1.4% +₹31.9b | 39.8% | PE78x | |
| RUBICON Rubicon Research | ₹1.72k | 6.5% +₹17.5b | n/a | PE99.1x | |
| 500420 Torrent Pharmaceuticals | ₹4.88k | 0.8% +₹15.3b | 32.4% | PE85.1x |
